Neurophet
KOE: 380550.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Junkil Been
- Headquarters
- Seoul, South Korea
- IPO year
- 2025
- Market cap
- ₩231.6B
- Website
- https://www.neurophet.com
Loading 380550…
Loading profile data…Frequently asked questions about 380550
What does Neurophet (380550.KQ) do?
Neurophet, Inc., operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases. The company offers Neurophet AQUA, AI-powered diagnosis assistant software for brain diseases; Neurophet SCALE PET, a software that quantitatively analyzes biomarkers targeted by...
Where does 380550.KQ trade?
Neurophet (380550.KQ) trades on the KOSDAQ.
What sector is 380550.KQ in?
Neurophet (380550.KQ) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Neurophet?
Junkil Been is the chief executive officer of Neurophet (380550.KQ).
Where is Neurophet headquartered?
Neurophet is headquartered in South Korea.
Does 380550.KQ pay a dividend?
Neurophet (380550.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 380550.KQ go public?
Neurophet (380550.KQ) completed its initial public offering in 2025.